Current risk of iatrogenic Creutzfeld-Jakob disease in the UK: Efficacy of available cleaning chemistries and reusability of neurosurgical instruments

Journal of Hospital Infection

Volumn 75, Issue 4, 2010, Pages 309-313

  Herve R ^a   Secker, T J ^a   Keevil, C W ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Creutzfeld Jakob disease; Risk assessment; Sterilisation; Surgical instruments

Indexed keywords

ARTICLE; CONTROLLED STUDY; IATROGENIC CREUTZFELDT JAKOB DISEASE; INSTRUMENT STERILIZATION; PRION DISEASE; RISK ASSESSMENT; SURGICAL INSTRUMENT; UNITED KINGDOM; CREUTZFELDT-JAKOB SYNDROME; DEVICES; EVALUATION STUDY; FLUORESCENCE MICROSCOPY; HUMAN; IATROGENIC DISEASE; MEDICAL DEVICE CONTAMINATION; NEUROSURGERY; PREVENTION AND CONTROL; PROCEDURES; RECYCLING; STAINING;

CREUTZFELDT-JAKOB SYNDROME; EQUIPMENT CONTAMINATION; EQUIPMENT REUSE; GREAT BRITAIN; HUMANS; IATROGENIC DISEASE; MICROSCOPY, FLUORESCENCE; NEUROSURGICAL PROCEDURES; PRPSC PROTEINS; RISK ASSESSMENT; STAINING AND LABELING; STAINLESS STEEL; STERILIZATION;

PRION PROTEIN; STAINLESS STEEL;

EID: 77954541599     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2010.01.024     Document Type: Article

References (23)

1. Lipscomb I.P., Sihota A.K., Keevil C.W. Comparison between visual analysis and microscope assessment of surgical instrument cleanliness from sterile service departments. J Hosp Infect 2008, 68:52-58.
2. Brown P. Transmissible spongiform encephalopathy in the 21st century: neuroscience for the clinical neurologist. Neurology 2008, 70:713-722.
3. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001, 24:519-550.
4. Mishra R.S., Basu S., Gu Y., et al. Protease-resistant human prion protein and ferritin are cotransported across Caco-2 epithelial cells: implications for species barrier in prion uptake from the intestine. J Neurosci 2004, 24:11280-11290.
5. Foster J.D., Hope J., Fraser H. Transmission of bovine spongiform encephalopathy to sheep and goats. Vet Rec 1993, 133:339-341.
6. Collinge J., Sidle K.C., Meads J., Ironside J., Hill A.F. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996, 383:685-690.
7. Weissmann C., Aguzzi A. Bovine spongiform encephalopathy and early onset variant Creutzfeldt-Jakob disease. Curr Opin Neurobiol 1997, 7:695-700.
8. Bruce M.E., Will R.G., Ironside J.W., et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997, 389:498-501.
9. Collinge J., Whitfield J., McKintosh E., et al. Kuru in the 21st century - an acquired human prion disease with very long incubation periods. Lancet 2006, 367:2068-2074.
10. Caramelli M., Ru G., Acutis P., Forloni G. Prion diseases: current understanding of epidemiology and pathogenesis, and therapeutic advances. CNS Drugs 2006, 20:15-28.
11. Hilton D.A. Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease. J Pathol 2006, 208:134-141.
12. Zobeley E., Flechsig E., Cozzio A., Enari M., Weissmann C. Infectivity of scrapie prions bound to a stainless steel surface. Mol Med 1999, 5:240-243.
13. Flechsig E., Hegyi I., Enari M., Schwarz P., Collinge J., Weissmann C. Transmission of scrapie by steel-surface-bound prions. Mol Med 2001, 7:679-684.
14. Dunstan R.A., Alpers M.P. Variant Creutzfeldt-Jakob disease: implications for the health care system. Aust NZ J Public Health 2005, 29:308-312.
15. Pana A., Jung M. Prion diseases and iatrogenic infections I. A review. Ig Sanita Pubbl 2005, 61:325-377.
16. Lumley J.S. The impact of Creutzfeldt-Jakob disease on surgical practice. Ann R Coll Surg Engl 2008, 90:91-94. Serious Hazards of Transfusion Committee.
17. Lipscomb I.P., Sihota A.K., Botham M., Harris K.L., Keevil C.W. Rapid method for the sensitive detection of protein contamination on surgical instruments. J Hosp Infect 2006, 62:141-148.
18. Hervé R., Collin R., Pinchin H.E., Secker T., Keevil C.W. A rapid dual staining procedure for the quantitative discrimination of prion amyloid from tissues reveals how interactions between amyloid and lipids in tissue homogenates may hinder the detection of prions. J Microbiol Methods 2009, 77:90-97.
19. Keevil C.W. Rapid detection of biofilms and adherent pathogens using scanning confocal laser microscopy and episcopic differential interference contrast microscopy. Water Sci Technol 2003, 47:105-116.
20. Barron R.M., Campbell S.L., King D., et al. High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo. J Biol Chem 2007, 282(49):35878-35886.
21. Lasmezas C.I., Deslys J.P., Robain O., et al. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 1997, 275:402-405.
22. Lipscomb I.P., Hervé R., Harris K., Pinchin H., Collin R., Keevil C.W. Amyloid-specific fluorophores for the rapid, sensitive in situ detection of prion contamination on surgical instruments. J Gen Virol 2007, 88:2619-2626.
23. Lipscomb I.P., Pinchin H.E., Collin R., Harris K., Keevil C.W. Are surgical stainless steel wires used for intracranial implantation of PrPsc a good model of iatrogenic transmission from contaminated surgical stainless steel instruments after cleaning?. J Hosp Infect 2006, 64(4):339-343.